Medicine is rapidly approaching a great advance that will augment or replace drugs with human cells for treating a range of intractable conditions, an expert in cell therapy told the Wisconsin Technology Council on June 26.
Jacques Galipeau, assistant dean for therapeutics discovery at the University of Wisconsin School of Medicine and Public Health, described the potential of building on the innate capacities of human cells that are manipulated to target particular diseases.
The strategy uses what he calls a “living cell pharmaceutical.”
Less than two years after Galipeau was hired to start the Program for Advanced Cell Therapy at the School of Medicine, PACT has obtained an FDA Investigational New Drug (IND) permit to test a treatment for complications of bone marrow transplant.
Read the full article here.